- Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients. Visser, P.J., Scheltens, P., Pelgrim, E., Verhey, F.R. Dementia and geriatric cognitive disorders. (2005)